Avanzanite Bioscience Appoints Sotiris Botozis as Managing Director for Southern Europe Amid Strategic Expansion and Unprecedented Growth Avanzanite Bioscience BV, a rapidly growing player in the European life sciences and…
FDA Grants Full Approval to Bayer’s VITRAKVI® (Larotrectinib), a Landmark TRK Inhibitor for Patients with NTRK Fusion-Positive Solid Tumors In a milestone for precision oncology, Bayer announced today that the…
Biologic Therapy Boosts Pregnancy Outcomes in High-Risk APS Patients Landmark Clinical Trial Finds Certolizumab Significantly Improves Pregnancy Outcomes in Women with Antiphospholipid Syndrome In a groundbreaking advancement for maternal-fetal medicine…
Survey: Americans Shocked by Rx Costs, Few Talk to Pharmacists A recent nationwide survey conducted by Lumicera Health Services— the specialty pharmacy arm of Navitus Health Solutions—has unveiled a paradox…
Two Major Trials Identify Effective Antibiotic Selection Method for Hospitalized Infection Patients In a significant advancement for infectious disease care and antibiotic stewardship, two large-scale clinical trials funded by the…
Amylyx Begins Dosing in Phase 1 LUMINA Trial of AMX0114 for ALS Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a biopharmaceutical company dedicated to the development of innovative treatments for neurodegenerative diseases,…
Textron Aviation Opens Second Plane Healthy Wellness Center & Pharmacy in Wichita to Enhance Employee Healthcare Access Textron Aviation Inc., a renowned aircraft manufacturer and a subsidiary of Textron Inc.…
California Advocates Urge Greater Access to Plasma-Derived Medicines In a compelling call to action, the California Rare Disease Access Coalition, Hemophilia Council of California, and the Plasma Protein Therapeutics Association…
NexThera Begins U.S. Trial with First Patient Dosed for Wet AMD Eye Drop NT-101 NexThera Co., Ltd., a biotechnology company at the forefront of ophthalmic innovation, announced a pivotal milestone…
Global Forecast: mRNA Vaccines & Therapeutics Market for Influenza, RSV, and CMV (2025) A new report titled “mRNA Vaccine and Therapeutics Market: Industry Trends and Global Forecasts to 2035 by…
GSK Invests $4 Million in Adult Vaccination Efforts, Doubling Down with New 2025 Commitment In a major push to improve adult immunization rates across the United States, GSK plc has…
LifeMine Doses First Participant in Phase 1 Trial of Novel Immunosuppressive LIFE-001 LifeMine Therapeutics Inc., a clinical-stage biopharmaceutical company redefining small molecule discovery through its proprietary genomic search platform, has…
